|
||
Robini Overdose |
||
History of GI ulceration; impaired cardiac, renal or hepatic function; hypertension; lactation. IV admin in patients with moderate or severe renal impairment; hypovolaemia or dehydration; asthma, porphyria. Monitor LFTs in patients on prolonged therapy. May prolong bleeding time; caution when used in patients with coagulation disorders or on anticoagulants. Prolonged therapy may increase risk of anaemia. 1st and 2nd trimester of pregnancy. Elderly, debilitated patients.
pregnancy:
Category B(Parenteral): Either animal-reproduction studies have not demonstrated a foetal risk but there are no controlled studies in pregnant women or animal-reproduction studies have shown an adverse effect (other than a decrease in fertility) that was not confirmed in controlled studies in women in the 1st trimester (and there is no evidence of a risk in later trimesters).
Category C(Ophth /
Topical): Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus.
Voltaren Emulgel should not be applied to an open wound (e.g. a graze or a cut) or to skin that has a rash (e.g. eczema). Voltaren Emulgel should not be applied for long periods of time over large areas of skin, unless prescribed by the doctor. Avoid contact with the eyes and mucous membranes.
Use in pregnancy & lactation: During pregnancy Voltaren Emulgel should not be used, especially during the last 3 months of pregnancy, as it could harm the unborn child or cause problems at delivery, unless specifically prescribed by a doctor. As a precaution, avoid using medicinal products during pregnancy and breast-feeding, if possible.
Do not use Voltaren Emulgel if the patient is breast-feeding.
Ask the doctor or pharmacist for advice before taking any medicine.
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|